Privia Health appoints Nancy Cocozza to Board of Directors, effective April 1, 2022

Privia Health Group, Inc.

Board expanded from 9 to 10; Nancy Cocozza elected director effective April 1, 2022.
Cocozza appointed to Audit Committee, replacing Will Sherrill.
She is a former Aetna senior VP and Medicare business leader with 30+ years in payer market.
Initial restricted stock unit award of $175,000 in common stock.
Enters standard indemnification agreement with Company.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Nancy Cocozza

Director

PRVA · Privia Health Group, Inc.

Effective: 2022-04-01
Filed: March 31, 2022, 7:59 PM ET

elected Nancy Cocozza to fill the newly created vacancy on the Board, effective April 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Nancy Cocozza was elected as Director at Privia Health Group, Inc..

Action: elected
Role: Director

Exact text from the filing

elected Nancy Cocozza to fill the newly created vacancy on the Board, effective April 1, 2022.

View on SEC.gov

Privia Health Group, Inc. filing history →

Source: SEC EDGAR

accession 0001759655-22-000041

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.